1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BIOGEN INC
Biogen Inc XNAS: BIIB

Biogen Inc Live Share Price Today, Share Analysis and Chart

Value Stock, Under Radar
about

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

Read More
126.08 -0.84 (-0.66%)
47.02% Fall from 52W High
1.1M
XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
54.5 / 100
Momentum Score
Technically Bearish
32.2 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
172
1Yr Price target upside is 37%
31 analysts

6

S

9

W

2

O

1

T

SWOT Analysis

Biogen Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Biogen Inc FAQ

How is Biogen Inc today?
Biogen Inc today is trading in the red, and is down by -0.66% at 126.08.
Biogen Inc is currently trading down -0.66% on an intraday basis. In the past week the stock fell -0.76%. stock has been down -8.88% in the past quarter and fell -45.61% in the past year. You can view this in the overview section.